Contract 75N93023P00689
Discovery Life Sciences, Llc · Department Of Health And Human Services · May 27, 2023
Discovery Life Sciences, Llc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on May 27, 2023 for $54,000 of work in biological product (except diagnostic) manufacturing. Performance is in Bethesda, MD. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- 75N93023P00689
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Special Studies/Analysis- Chemical/Biological
- Place of performance
- Bethesda, MD
- First action
- May 27, 2023
Description
OLINK PROTEOMICS
Modification timeline
-
May 27, 2023Base award$54.3K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93023P00689?
Contract 75N93023P00689 is a federal contract awarded to Discovery Life Sciences, Llc by Department Of Health And Human Services on May 27, 2023 for $54,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75N93023P00689?
Discovery Life Sciences, Llc won contract 75N93023P00689 from Department Of Health And Human Services.
How much is contract 75N93023P00689 worth?
Contract 75N93023P00689 has obligated $54,000 to date.